Despite significant advances in wound dressing materials, a critical challenge remains in developing a single multifunctional platform that simultaneously provides mechanical integrity, controlled bioactive delivery, and broad-spectrum antimicrobial protection for complex and infected wounds. To address this gap, the present study synthesized and evaluated an innovative alginate-chitosan-based composite hydrogel reinforced with hydroxyapatite nanoparticles (HA) and thyme extract ( Thymus vulgaris ) for advanced wound dressing applications. The primary goal was to create a multifunctional system with optimized mechanical, swelling, biological, and antimicrobial properties. FESEM analyses revealed a uniform distribution and porous morphology in the final sample (Alg/HA/Chi/Ext), while XRD results confirmed a gradual decrease in crystallite size and crystallinity degree from 89.5% for pure HA to 21.7% for the final composite, indicating enhanced amorphous character and intermolecular interactions. Tensile testing demonstrated a significant improvement in the UTS (50 MPa) and, notably, toughness (1087.5 kJ/m³) of the final sample compared to pure alginate hydrogel. This composite exhibited high swelling capacity (766%) similar to pure alginate, but with much better structural stability. The MTT assay confirmed superior biocompatibility and increased cell viability (88% after 72 hours). Release studies showed a biphasic profile for the final sample, which followed the Korsmeyer-Peppas kinetic model. Significantly, this hydrogel demonstrated potent antimicrobial activity against Bacillus cereus (98.99% inhibition) and the fungus Aspergillus flavus (99.12% inhibition), with very low MIC values (below 5 µg/mL). The developed Alg/HA/Chi/TE hydrogel exhibited significantly enhanced antimicrobial activity (p < 0.05) and superior extract-loading capacity compared with the other formulations, while maintaining controlled release behavior and acceptable biodegradation characteristics. These findings demonstrate the potential of the proposed multifunctional composite as a promising platform for sustained delivery of natural therapeutics in wound-healing applications. Nevertheless, further in vivo studies and sterilization validation are required before clinical translation.
No takes yet. Share an insight, caveat, or question.
Karimi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: